Pharmacy Podcast Network

Academia & Addiction | Pain Pod

Earl Simmons (DMX) gonna give it to ya, a new definition of pain that is!
 
Back in 2009, a prominent study showed that U.S. Schools of Medicine were barely covering the topic of pain management in respective curricula (weighing in at a mere 9 hours on average), which paled in comparison to numerous other medical conditions. Obviously, the rest of healthcare professional schools, that’s us in pharmacy too, had a reconning to take action and amp up the education on pain management, and of course substance use disorder (SUD), commonly referred to as addiction.
 
It's been a wild ride, and in this episode of the Pain Pod, Mark “Pain Guy” Garofoli sits down for a chat with Dr. Lucas Hill, PharmD on the intersection of Academia (the Ivory Tower) and SUD.
 
Come one, come all, to the Pain Pod!!!
 
Episode References
 
·     June 10th, 2022 Time Magazine article “Fewer Than Half of U.S. Pharmacies Carry One of the Most Effective Drugs for Opioid Abuse”: https://time.com/6186319/buprenorphine-overdoses-pharmacy-drug-treatment/
·     AACP Opioid Efforts Database Submission: https://www.aacp.org/opioid
·     APhA Institute on SUD: https://aphainstitute.pharmacist.com/
·     Chronicle of Higher Education Article: https://www.chronicle.com/article/one-university-takes-on-the-opioid-crisis/
2011 Article on U.S. Schools of Medicine 9 hours of Pain Education: https://pubmed.ncbi.nlm.nih.gov/21945594/
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Managed Care Implications of Cost, Disease Burden, and Quality of Life in Myelofibrosis | PTCE Pharmacy Connect

Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.
The Managed Care Implications of Cost, Disease Burden, and Quality of Life in Myelofibrosis
 
Educational Objective: Recognize the quality-of-life impacts and cost of therapy challenges patients with myelofibrosis face and explore strategies available to better manage this diagnosis.
 
 
 
Melissa Pozotrigo, PharmD, BCOP
Senior Clinical Pharmacist
OncoHealth
Atlanta, Georgia
 
Melissa Pozotrigo, PharmD, BCOP, has no financial relationships with commercial interests to disclose.
 
 
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-397-H01-P. The activity is available for CE credit through August 29, 2023.
This activity is supported by an educational grant from Incyte Corporation.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Achieving Treatment Goals in Myelofibrosis with JAK Inhibitors and Emerging Therapies | PTCE Pharmacy Connect

Educational Objective: Outline the standard treatment options for myelofibrosis as well as review clinical data for Janus kinase inhibitors and emerging targeted therapies.
 
 
Victoria Nachar, PharmD, BCOP
Clinical Pharmacist Specialist, Hematology
University of Michigan Rogel Cancer Center
Clinical Assistant Professor
University of Michigan College of Pharmacy
Ann Arbor, Michigan
 
 
Victoria Nachar, PharmD, BCOP, has no financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-396-H01-P. The activity is available for CE credit through August 29, 2023.
This activity is supported by an educational grant from Incyte Corporation.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Setting the Scene in Myelofibrosis Treatment and Management | PTCE Pharmacy Connect

Educational Objective: Review the etiology and pathophysiology of myelofibrosis, including the World Health Organization classification and diagnostic criteria.
 
 
Victoria Nachar, PharmD, BCOP
Clinical Pharmacist Specialist, Hematology
University of Michigan Rogel Cancer Center
Clinical Assistant Professor
University of Michigan College of Pharmacy
Ann Arbor, Michigan
 
Victoria Nachar, PharmD, BCOP, has no financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-381-H01-P. The activity is available for CE credit through August 29, 2023.
This activity is supported by an educational grant from Incyte Corporation.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Creating Systems For High Performing Integrative Pharmacies w/Tyson Clarke | Holistic Pharmacy Podcast

Hello beautiful listeners! I’m so excited to share this episode with you diving into the journey of one psychology-majoring basketball player turned-brilliant market researcher turned-pharmacy performance coach. Tyson Clarke has studied the highest performers in several industries to come up with a customized approach to help independent pharmacies to serve their patients’ needs with an integrative approach while creating revenue streams to drive their business forward.
Tyson started his career in elite sport, and was dismayed with how scarce effective training was present in the corporate world.
Through working in Australian community pharmacy, and being more committed to results than positive feedback - he's created a tool for effective distribution of culturally sensitive intelligence - voiceta. A speech operated platform to train social skills in the same manner an elite athlete would.
He's currently excited about changing the cultural landscape by helping people tell the truth , and gain communication skills with his extremely effective Assertiveness training.
Connect and train with Tyson at Motherofskill.com.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Helping Pharmacists Figure Out ”The How” | Pharmacy Podcast Nation

Dr. DeLon Canterbury PharmD, is a Board Certified Geriatric Pharmacist who focuses on the special needs of older patients who may have concurrent illnesses taking multiple medications. His extensive background ranges from Personalized Care, Medication Deprescribing, to Health Cost Savings! He was inspired to pursue this calling, because of his late grandmother who passed from complications of Dementia, where a medication had been incorrectly prescribed leading to her health declining rapidly. This fatal medication error could have been avoided had a trained Geriatric Pharmacist paid close enough attention to her medication history. He never want any more patients of his or loved ones to endure what my family had to because of something preventable, which is why he founded GeriatRx.
Dr. Jerrica Dodd, PharmD is the founder of the PharmaSis Magazine. The PharmaSis Magazine, where the goal is to celebrate women in pharmacy. These women have determined to define their careers and ultimately leave a legacy while building the lives of which they dream. 
Learn more about your ad choices. Visit megaphone.fm/adchoices

CGM Data Interpretation Made Easy | Real Time Real Talk

Disclaimer: This podcast is not approved for CME credit. Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice. All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom G6 User Guide. For product-related questions, please refer to the instructions for use. For complete safety information, go to dexcom.com/safety-information. 
Smart devices are sold separately. For a list of compatible smart devices, visit: dexcom.com/compatibility. 
 
Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
 
Data from collaborator devices and products must be verified by those collaborator devices and products. Users should confirm data and connections with their collaborator devices and products.
The Dexcom G6 Continuous Glucose Monitoring System (Dexcom G6 System) is a real time, continuous glucose monitoring device indicated for the management of diabetes in persons aged 2 years and older. 
Egils Bogdanovics, MD and Tomas Grace, MD are paid spokespeople for Dexcom.
Dexcom G6 System User Guide
 
Safety Information
 
Dexcom Clarity Website
 
About Hello Dexcom 
Learn more about your ad choices. Visit megaphone.fm/adchoices

Tomorrow Happens Here - NACDS TSE 2022

The NACDS Total Store Expo is the industry’s largest gathering of its most influential leaders. It is a combination of both strategic and tactical business meetings between existing and new trading partners and is attended by industry decision-makers. It will give you and your company a unique opportunity to gain new insights into today’s evolving marketplace and set your course for the future. This is also an excellent opportunity for retail media executives to engage the supplier community.
We talk with Dr. Christie R. Boutte, PharmD, the Senior Vice President, Reimbursement, Innovation and Advocacy with the NACDS. 
Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacists Inside the Intelligent Health Ecosystem | Pharmacy Podcast Nation

A new report penned by Pamela Spence, EY’s Global Health Sciences and Wellness Industry, explores how heath care in the future will be transformed by a living, intelligent ecosystem that enables care delivery anytime and anywhere, and how pharmacists can utilize AI technologies to make health care even more human.
 
According to EY, there is no single new technology that holds the key to the future of health care. Rather, as technologies such as sensors, cloud computing, AR/VR and 5G continue to evolve and converge with more advanced technologies, like quantum computing and the metaverse, they are enabling the creation of a growing internet of medical things (IoMT), which will extend itself everywhere – beginning with sensors in and on our bodies, to our homes and working environments, and beyond, to smart specialist care facilities. The result: unprecedented growth (36% CAGR over the next three years) in quantity and quality of health data available. Data – particularly the disparate, often unstructured data generated from our daily lives, which is often relevant to health outcomes – requires new analytical tools to turn it from raw information into actionable insights.
 
EY identified two key areas for pharmacists to focus in order to create value in this intelligent health ecosystem of the future:
 
·       Personalized insights through artificial intelligence – AI offers a means to connect, combine and interrogate unstructured data differently and unlock actionable insights. With the power of AI, pharmas can begin to link the huge volumes of data generated and the vast array of technological tools being developed into a comprehensive, integrated smart health system. This data-driven smart system enables the breakdown of silos between care settings and optimizes decision-making across the patient journey.
 
·       User experience defines the value – The explosion in data and technological innovation offers pharmas a way to reinvent care as a patient-centered, personalized health experience. To succeed in this reinvented world companies will need to consider not only traditional clinical metrics, but also the non-clinical measures which capture the subjective reality of the patient’s own experience. Use of these measures to generate actionable insights via AI will be the pivot for the move from data to value and thus, for BioPharma companies to gain fair reimbursement for innovation and new products.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Access to Community Pharmacies: A Nation-Wide Geographic Information Systems Cross-sectional Analysis

Pharmacy accessibility is key for the emerging role of community pharmacists as providers of patient-centered, medication management services in addition to traditional dispensing roles. Community pharmacies may serve as accessible locations for patient-centered, medication management services that enhance the health and wellness of communities. Although chain pharmacies represent the majority of pharmacy locations across the country, access to community pharmacies in rural areas predominantly relies on regional franchises and independently owned pharmacies. 
Guest: 
Lucas A. Berenbrok, PharmD 
Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy 
Download the journal article here: https://www.japha.org/article/S1544-3191(22)00233-3/fulltext#%20
Learn more about your ad choices. Visit megaphone.fm/adchoices